Skip to content
2000
Volume 16, Issue 5
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Aims: The aim of this review is to survey the recent progress made in developing the nanoparticles as antifungal agents especially the nano-based formulations being exploited for the management of Candida infections. Discussion: In the last few decades, there has been many-fold increase in fungal infections including candidiasis due to the increased number of immunocompromised patients worldwide. The efficacy of available antifungal drugs is limited due to its associated toxicity and drug resistance in clinical strains. The recent advancements in nanobiotechnology have opened a new hope for the development of novel formulations with enhanced therapeutic efficacy, improved drug delivery and low toxicity. Conclusion: Metal nanoparticles have shown to possess promising in vitro antifungal activities and could be effectively used for enhanced and targeted delivery of conventionally used drugs. The synergistic interaction between nanoparticles and various antifungal agents have also been reported with enhanced antifungal activity.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180815666181015145224
2019-05-01
2025-06-01
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180815666181015145224
Loading

  • Article Type:
    Review Article
Keyword(s): Antifungal; Candida albicans; candidiasis; nanobiotechnology; nanoparticles; synergy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test